среда, 18 января 2017 г.

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers


CoLucid Pharmaceuticals led the biotech stocks Wednesday morning in premarket moving, seeing its share price skyrocket more than 30% ahead of market's open. CoLucid, which is developing a pill to treat migraine headaches, is being acquired by Eli Lilly for $960 million in cash.



from Biotech News